UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 109

Sortiert nach

Patient groups in Rheumatoid arthritis identified by deep learning respond differently to biologic or targeted synthetic DMARDs

PLoS computational biology, 2023-06, Vol.19 (6), p.e1011073-e1011073

2023

Volltextzugriff (PDF)

Design and Execution of Sustainable Decentralized Clinical Trials

Clinical pharmacology and therapeutics, 2023-10, Vol.114 (4), p.802-809

2023

Volltextzugriff (PDF)

Pharmacoepidemiology and Big Data Analytics: Challenges and Opportunities when Moving towards Precision Medicine

Chimia, 2019-12, Vol.73 (12), p.1012

Burden, Andrea M

2019

Volltextzugriff (PDF)

Identification of novel off targets of baricitinib and tofacitinib by machine learning with a focus on thrombosis and viral infection

Scientific reports, 2022-05, Vol.12 (1), p.7843-7843, Article 7843

2022

Volltextzugriff (PDF)

Lower odds of remission among women with rheumatoid arthritis: A cohort study in the Swiss Clinical Quality Management cohort

PloS one, 2022-10, Vol.17 (10), p.e0275026-e0275026

2022

Volltextzugriff (PDF)

Comorbidity clusters associated with newly treated type 2 diabetes mellitus: a Bayesian nonparametric analysis

Scientific reports, 2022-11, Vol.12 (1), p.20653-20653, Article 20653

2022

Volltextzugriff (PDF)

External validation of the PAR-Risk Score to assess potentially avoidable hospital readmission risk in internal medicine patients

PloS one, 2021-11, Vol.16 (11), p.e0259864

2021

Volltextzugriff (PDF)

When to Start and Stop Bone-Protecting Medication for Preventing Glucocorticoid-Induced Osteoporosis

Frontiers in endocrinology (Lausanne), 2021-12, Vol.12, p.782118-782118

2021

Volltextzugriff (PDF)

Methodological guidance for the use of real-world data to measure exposure and utilization patterns of osteoporosis medications

Bone Reports, 2024-03, Vol.20, p.101730-101730, Article 101730

2024

Volltextzugriff (PDF)

Cardiovascular Safety Profile of Romosozumab: A Pharmacovigilance Analysis of the US Food and Drug Administration Adverse Event Reporting System (FAERS)

Journal of clinical medicine, 2021-04, Vol.10 (8), p.1660

2021

Volltextzugriff (PDF)

Incidence of Differentiation Syndrome Associated with Treatment Regimens in Acute Myeloid Leukemia: A Systematic Review of the Literature

Journal of clinical medicine, 2020-10, Vol.9 (10), p.3342

2020

Volltextzugriff (PDF)

Observational cross-sectional case study of toxicities of antifungal drugs

Journal of global antimicrobial resistance., 2022-06, Vol.29, p.520-526

2022

Volltextzugriff (PDF)

Duration of Bisphosphonate Drug Holidays in Osteoporosis Patients: A Narrative Review of the Evidence and Considerations for Decision-Making

Journal of clinical medicine, 2021-03, Vol.10 (5), p.1140

2021

Volltextzugriff (PDF)

Corrigendum: When to Start and Stop Bone-Protecting Medication for Preventing Glucocorticoid-Induced Osteoporosis

Frontiers in endocrinology (Lausanne), 2022-03, Vol.13, p.877512-877512

2022

Volltextzugriff (PDF)

Interrupted time series analysis in drug utilization research is increasing: systematic review and recommendations

Journal of clinical epidemiology, 2015-08, Vol.68 (8), p.950-956

2015

Volltextzugriff (PDF)

Drug Triggers and Clinic of Acute Generalized Exanthematous Pustulosis (AGEP): A Literature Case Series of 297 Patients

Journal of clinical medicine, 2022-01, Vol.11 (2), p.397

2022

Volltextzugriff (PDF)

Community Pharmacist-Administered COVID-19 Vaccinations: A Pilot Customer Survey on Satisfaction and Motivation to Get Vaccinated

Vaccines (Basel), 2021-11, Vol.9 (11), p.1320

2021

Volltextzugriff (PDF)

Longitudinal associations between body mass index and changes in disease activity and radiographic progression in rheumatoid arthritis patients treated with infliximab

Rheumatic & musculoskeletal diseases open, 2023-10, Vol.9 (4), p.e003396

2023

Volltextzugriff (PDF)

Comparison of Fracture Identification Using Different Definitions in Healthcare Administrative (Claims) Data

Pharmacy, 2023-03, Vol.11 (2), p.53

2023

Volltextzugriff (PDF)

Blood eosinophilia, use of inhaled corticosteroids, and risk of COPD exacerbations and mortality

Pharmacoepidemiology and drug safety, 2018-11, Vol.27 (11), p.1191-1199

2018

Volltextzugriff (PDF)

Baricitinib and tofacitinib off‐target profile, with a focus on Alzheimer's disease

Alzheimer's & dementia : translational research & clinical interventions, 2024-01, Vol.10 (1), p.e12445-n/a

2024

Volltextzugriff (PDF)

Bone fragility in diabetes: novel concepts and clinical implications

The lancet. Diabetes & endocrinology, 2022-03, Vol.10 (3), p.207-220

2022

Volltextzugriff (PDF)

Comparison of Psoriatic Arthritis and Rheumatoid Arthritis Patients across Body Mass Index Categories in Switzerland

Journal of clinical medicine, 2021-07, Vol.10 (14), p.3194

2021

Volltextzugriff (PDF)

Thromboembolic Safety Reporting of Tofacitinib and Baricitinib: An Analysis of the WHO VigiBase

Drug safety, 2020-09, Vol.43 (9), p.881-891

2020

Volltextzugriff (PDF)

A Network Analysis of Drug Combinations Associated with Acute Generalized Exanthematous Pustulosis (AGEP)

Journal of clinical medicine, 2021-09, Vol.10 (19), p.4486

2021

Volltextzugriff (PDF)

1 – 25 von 109

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(106)
Mit Volltextzugriff
(102)

Publikationsform

Artikel
(108)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Patient groups in Rheumatoid arthritis identified by deep learning respond differently to biologic or targeted synthetic DMARDs

Design and Execution of Sustainable Decentralized Clinical Trials

Pharmacoepidemiology and Big Data Analytics: Challenges and Opportunities when Moving towards Precision Medicine

Identification of novel off targets of baricitinib and tofacitinib by machine learning with a focus on thrombosis and viral infection

Lower odds of remission among women with rheumatoid arthritis: A cohort study in the Swiss Clinical Quality Management cohort

Comorbidity clusters associated with newly treated type 2 diabetes mellitus: a Bayesian nonparametric analysis

External validation of the PAR-Risk Score to assess potentially avoidable hospital readmission risk in internal medicine patients

When to Start and Stop Bone-Protecting Medication for Preventing Glucocorticoid-Induced Osteoporosis

Methodological guidance for the use of real-world data to measure exposure and utilization patterns of osteoporosis medications

Cardiovascular Safety Profile of Romosozumab: A Pharmacovigilance Analysis of the US Food and Drug Administration Adverse Event Reporting System (FAERS)

Incidence of Differentiation Syndrome Associated with Treatment Regimens in Acute Myeloid Leukemia: A Systematic Review of the Literature

Observational cross-sectional case study of toxicities of antifungal drugs

Duration of Bisphosphonate Drug Holidays in Osteoporosis Patients: A Narrative Review of the Evidence and Considerations for Decision-Making

Corrigendum: When to Start and Stop Bone-Protecting Medication for Preventing Glucocorticoid-Induced Osteoporosis

Interrupted time series analysis in drug utilization research is increasing: systematic review and recommendations

Drug Triggers and Clinic of Acute Generalized Exanthematous Pustulosis (AGEP): A Literature Case Series of 297 Patients

Community Pharmacist-Administered COVID-19 Vaccinations: A Pilot Customer Survey on Satisfaction and Motivation to Get Vaccinated

Longitudinal associations between body mass index and changes in disease activity and radiographic progression in rheumatoid arthritis patients treated with infliximab

Comparison of Fracture Identification Using Different Definitions in Healthcare Administrative (Claims) Data

Blood eosinophilia, use of inhaled corticosteroids, and risk of COPD exacerbations and mortality

Baricitinib and tofacitinib off‐target profile, with a focus on Alzheimer's disease

Bone fragility in diabetes: novel concepts and clinical implications

Comparison of Psoriatic Arthritis and Rheumatoid Arthritis Patients across Body Mass Index Categories in Switzerland

Thromboembolic Safety Reporting of Tofacitinib and Baricitinib: An Analysis of the WHO VigiBase

A Network Analysis of Drug Combinations Associated with Acute Generalized Exanthematous Pustulosis (AGEP)

Suchergebnisse filtern